Stock Chart
MRNA
Type: SELL wallstreet
Strike: $165
Premium: $39.00
Expiry: Jun 17, 2027
Target: $89
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About MRNA - Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Key Statistics
More MRNA Analysis
This MRNA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MRNA's price movements with trendlines, gamma walls, and key support/resistance levels.